来凯医药有限公司（02105）于2026年1月5日提交的2025年12月股份变动月报显示，公司截至2025年12月31日的注册股本为5,000,000,000股，面值每股0.00001美元，注册股本总额50,000美元，未发生变化。
报告期内，公司已发行股份总数为446,466,350股，与上月保持一致，库藏股数量为零，无新增发行、购回及注销股本活动。同时，公司于2018年及2023年先后采纳的购股权计划在当月亦无行使、授出或失效数量的变动，相关可行使股份期权数量保持不变；2024年股份奖励计划暂无发股或转让股份记录。
公司确认已遵守香港联交所《上市规则》及相关法律法规的要求。本次月报由联席公司秘书柯晨煜签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.